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BACKGROUND: Bone marrow is extremely vulnerable to damage 
caused by radiation therapy. Hence, bone marrow suppression is an 
important side effect of radiotherapy. Effective use of radiotherapy 
is therefore compromised by radiation-related injuries.  
MATERIAL AND METHODS: Six Guinea-pigs were recruited for 
the study of which three were subjected to total body irradiation 
with Co60 while the other three served as controls. Bone marrow 
and peripheral blood samples were collected before and at days 9, 
14 and 21, post irradiation. Manual and automated counts were 
performed for bone marrow nucleated cells and peripheral blood 
cells respectively.  
RESULTS: Declining bone marrow cellularity was evident 
immediately post irradiation. Mean ± SD of marrow cell counted 
per mm3 were 121,924±281, 87,603±772, 121,367±375 and 
122,750±1000 pre-irradiation and days 9, 14 and 21, post-
irradiation (p-values 0.10, 0.27 and 0.29 respectively). Significant 
drops in counts were noticed on day 9 post-irradiation for all red 
cell parameters (p-values <0.05), for Total White Blood Cell Count 
and Neutrophil count (p-values <0.05) and also on days 14 and 21 
for Lymphocytes (p-values <0.05) and on day 21 for 
Eosinophil/Basophil/Monocytes (p-value <0.05). A significant drop 
in platelets counts was also noticed on day 9 (p-value <0.05) which 
significantly increased above pre-irradiation value on day 21.  
CONCLUSION: Total body irrradiation with Co60 significantly 
affects the bone marrow with maximum reductions in marrow 
nucleated cells and peripheral blood cells counts on day 9 post 
irradiation.  




Ionizing Radiation Therapy or Radiotherapy is the use of Ionizing 
Radiation (IR) for the treatment of radio-sensitive malignancies. It is 
an indispensable treatment modality for cancer, alone or supported 
with surgery and or chemotherapy. It consists of electrons and 
gamma rays or as alternative radioisotope. Commonly used isotopes 
include  Iodine125, Iridium192, Strontium89, Iodine131, Ytrium90 and 
Cobalt60.  
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IR produces free radicals which specifically 
damage DNA. For curative use, the dose of IR 
delivered to tumour cells is optimized while 
minimizing the dose delivered to the normal 
surrounding tissues. However, the effective use of 
IR is compromised by radiation-related injuries or 
side effects. The important role of radiation-
damaged bone marrow, skin and gastrointestinal 
tract epithelium in the severity of the acute 
radiation illness as well as those of the central 
nervous system, lungs, heart, liver, kidney and 
gonads has been well elucidated (1-4). Bone 
marrow is extremely vulnerable to damage caused 
by radiation therapy (5). Hence, bone marrow 
suppression is one of the most important side 
effects of radiotherapy. This has adverse effects 
on the success of cancer treatment (5). However, 
the mechanisms through which IR induces BM 
injury remains poorly understood (6), nor has it 
an effective treatment been developed to 
ameliorate the injury (7). Long term exposure to 
even low doses of radiation can affect 
proliferating cells (8).  
IR destroys both mature blood cells and 
hematopoietic progenitor/stem cells in the bone 
marrow. While loss of mature blood cells is a key 
factor in radiation morbidity, mortality is believed 
to occur due to prolonged myelo-suppression due 
to loss of Hematopoietic Progenitor Cells (HPC) 
and primitive Hematopoietic Stem Cells (HSC) 
(5,9).  
The impacts of exposure to IR on human and 
animal bone marrow have been studied by 
various researchers. Unlike the recent studies that 
centred on human bone marrow, most of the early 
studies were conducted on laboratory animals. 
The assay in which much of the experimental data 
is based is the spleen colony method of Till and 
McCulloch in which survival fraction of 
irradiated mouse cells is inversely proportional to 
radiation dose (10,11). IR has also been shown to 
significantly reduce hematopoietic cellularity, 
megakaryocytes counts and raised myeloid/ 
erythroid ratio due to erythroid hypoplasia in 
irradiated mice.   
Radiation induced human bone marrow 
injury from Magnetic Resonance Imaging (MRI) 
was noticed 6 to 12 months after radiotherapy and 
most evident 5 to 6 years after. The authors of 
this study also reported partial and complete 
recovery 2 to 9 years and 10 to 23 years after 
exposure respectively (12).  
Sahid et al. (13) noticed a decline in most 
haematological parameters when radiation-
exposed workers were compared with non 
radiation-exposed workers. In their study, MCH 
was mostly affected. Also, statistically significant 
differences were noticed in the MCHC and 
lymphocytes, with a decline in platelets, 
hematocrit and lymphocytes, whereas neutrophil 
was found to be elevated in association with 
Annual Average Effective Dose (AAED) (0.29-
1.91) mSv. 
Clinical applications of experimental data for 
bone marrow kinetics in animal models have not 
been realy successful. Future strategies in which 
radiotherapy will be used for treatment of human 
malignancies require more studies both in animals 
and human. These studies will further highlight 
among other things, bone marrow toxicity effects 
of radiotherapy. In modern practice, radiation 
doses as low as 2.0Gy are used in non-
myeloablative bone marrow transplantation 
because of the believe that this dose does not 
destroy host bone marrow but causes sufficient 
immune suppression to promote graft 
engraftment. This study was conducted on guinea 
pigs because of several biological similarities to 
humans and also because they are validated 
experimental animal models (14-16). Hence, for 
this study, we decided to evaluate the impact of a 
single 2.0Gy dose of Cobalt60  IR on the bone 
marrow and peripheral blood cells counts of 
guinea pigs. 
 
MATERIAL AND METHODS 
 
Animal source: Six young male Guinea-pigs, 
approximately 450 gram in weight, obtained from 
the animal house, Ladoke Akintola University of 
Technology College of Medicine Osogbo, Osun-
State, Nigeria were recruited for the study. They 
were labeled A, B, C, D, E and F and kept in the 
animal house of the Department of Anatomy, 
University of Ilorin in a temperature and 
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humidity-controlled room that was maintained on 
a 12-hour light and dark cycle. Food and water 
were available ad libitum throughout the 
experiment. Animals were treated according to 
the National and European Union directive 
2010/63/EU guidelines for handling animals used 
for scientific purposes. Guniea-pigs labeled A, B 
and C were subjected to lethal dose (2.0Gy at 
98.56cGy/minute) of Total Body Irradiation with 
Co60 and returned to the animal house. Guinea 
pigs D, E and F served as controls. 
 
Method of irradiation of the Guinea-pig: 
Irradiation was performed at University College 
Hospital Ibadan, one of the few centers in Nigeria 
that have facility for radiotherapy. The method 
described by Harris (17) was adopted. After 
general anesthesia using intra-muscular ketamine 
5mg/kg body weight plus 1 mg Atropine, each 
Guinea-pig was placed in a cotton-gauze bag and 
positioned lying on the side. Each animal was 
given 200r (2.0Gy) whole-body gamma-
irradiation under general anaesthetic, using a Co60 
therapy unit as a source, at a dose rate of 
98.560cGy/minute. 
After-care of the irradiated animals: To 
minimize the two hazards enumerated by Harris 
(17), i.e. the danger of internal haemorrhage from 
minor trauma and the risk of infection, resulting 
from the effects of irradiation on haemopoietic 
tissues, each irradiated animal was kept in a 
separate cage and excessive handling avoided 
until it was due for sacrifice. Each animal was 
adequately fed and given adequate supply of 
water. 
Bone marrow harvest and peripheral blood 
collection, pre and 9th, 14th and 21st days post 
irradiation: Bone marrow and peripheral blood 
cells counts were performed pre irradiation and 
on days 9, 14 and 21 post irradiation. Previous 
studies reported that bone marrow appears to be 
in the initial stage of final recovery of 
haemopoiesis on day 14 post irradiation and will 
be immediately followed by the reappearance of 
definitive precursor cells. Hence, days 14 and few 
days before (day 9) and few days after (day 21) 
were selected for bone marrow harvest and 
peripheral blood cells counts.  
 
Bone marrow harvest: The method described by 
Arthur et al. (18) was employed. Each animal was 
strapped to the table with dorsum presenting and 
extremities extended. The hair over sacral area 
was shaved and the skin sterilized with 100% 
alcohol. The antero-superior border of iliac crest 
was identified.  A sterile 20 gauge Quincke spinal 
tap needle about one and half inches long was 
inserted through the skin and muscle close to the 
iliac crest. Upon reaching the periosteum, the 
needle was rotated and with boring movement 
pushed until embedded in the bone. The stylet 
was removed and another 20 ml syringe used to 
aspirate about 0.2 ml of marrow. A drop was 
immediately placed on a clean glass slide to make 
thin film while the rest was aspirated into a bottle 
containing EDTA and immediately processed. 
The needle and the attached syringe were 
removed from the animal and discarded.   
Peripheral blood collection: Two milliliters of 
venous blood were collected aseptically from the 
Lateral Saphenous vein from each animal using 
the method described by Malene, MB et al (19) 
according to protocols approved by the Danish 
Animal Experimentation Inspectorate under the 
Ministry of Food, Agriculture and Fisheries. The 
samples were dispensed into bottles containing 
EDTA and analyzed immediately. 
Bone marrow staining and counting: Two films 
were made separately and stained with May 
Grunwald and Giemsa stains following the 
method described by John V. Dacie and S.M. 
Lewis (20). Nucleated cells and megakaryocytes 
counts were performed similarly. 
Peripheral blood cell counting: The collected 
blood was mixed well and inserted into Sysmex 
Automated Analyser Xp-300 by Sysmex 
Corporation 1-5-1 Wakinohama, Kaignodori, 
Chuo-ku, Kobe, 651-0073, Japan. Haemoglobin 
concentration (HB) in g/dl, Packed Cell Volume 
in % (PCV), Total Red Cell count (TRBC) x 
109/L, Mean Corpuscular Volume (MCV) in fl, 
Mean Corpuscular Haemoglobin (MCH) in pg, 
Mean Corpuscular Haemoglobin Concentration 
(MCHC) in g/dl, Total White Blood Cell counts 
(TWBC) x109/l and its differentials in % 
[Neutrophils (NEUT),  Lymphocytes (LYMP) 
and Eo sinophil/Basophil/Monocytes 
(EOS/BAS/MON), Platelets (PLT) x 109/l counts 
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and also Mean Platelet Volume (MPV) were 
measured. 
Statistical analysis: The results were expressed 
as mean ± standard deviation. Statistical 
differences between tests and controls and 
between pre- and post-irradiation values were 
calculated using student paired sample t-test. Data 
analysis was performed using Statistical Package 
for the Social Sciences, version 20. A p-value of 




Microscopic observation of harvested bone 
marrow and marrow cells counting: Prior to 
irradiation, marrows were normocellular with 
normal myelopoiesis, erythropoiesis, 
lymphopoiesis and megakaryopoiesis and 
Myeloid: Erythroid ratio of 3:1. Mean±SD of 
marrow cell counted was 121,924±281/mm3 
(Table 1). 
 A decline in bone marrow cellularity was 
noticed immediately post-irradiation up till day 9, 
but it started to rise again till day 21. Mean ± SD 
of marrow cell counted was 87,603±772, 
121,367±375 and 122,750±1000/mm3 on days 9, 
14 and 21 with p-values <0.01, 0.27 and 0.29 
respectively, (Table 1). 
 
 
Table 1: Effects of Ionizing Radiation on the Marrow Cell Counts. 
 
 





Pre  0 121,924.67±281.12 122,460.33±491.67 0.21 
Post  9 87,603.33±772.42 122,508.33±574.101 0.00 
p 0.00   
14 121,367.33±375.75 122,032.33±60.48 0.09 
p 0.27   
21 122,750±1000.61 122,699.67±834.17 0.95 
p 0.29   
 
 
PERIPHERAL BLOOD CELLS 
  
Erythroid cells: A significant difference between 
test and control results was noticed on day 9 post- 
irradiation for all red cell parameters and also on 
days 14 and 21 MCV and on day 21 for HB. No 
significant differences between tests and controls 
were noticed in these parameters at other stages 
of the study (Tables 2 and 3). When pre-
irradiation and post irradiation results were 
compared, a significant drop was noticed in all 
the erythroid parameters on day 9 (p-values 0.01, 
0.01, 0.01, 0.02, 0.00 and <0.01, for HB, PCV, 
RBC, MCV, MCH and MCHC respectively). 
Subsequently, a significant increase above pre-
irradiation values was noticed only in HB, p-
value 0.02 (Table 2). 
Myeloid cells: No significant differences was 
noticed in the pre-irradiation results for the tests 
and controlsfor TWBC, NEUT, LYMP, and 
EOS/BAS/MON, with p-values 0.12, 0.42, 0.42 
and 0.84 respectively, (Table 4). Like the results 
for erythroid cells, a significant drop was noticed 
for TWBC and NEUT on day 9 post irradiation 
(p-values <0.01, 0.04 respectively) but for LYM 
on days 14 and 21 (p-value 0.05 and <0.01 
respectively) and EOS/BAS/MON on day 21 (p-
value 0.01) (Table 4).   
When comparison was made between pre- and 
post-irradiation results, a significant reduction 
was noticed in the TWBC on day 9 (p-value 
<0.01) but this subsequently rose up to the pre-
irradiation value. This significant reduction was 
noticed on days 9 and 14 for NEUT (p-values 
0.05), on days 14 (p-value 0.03) and 21 (p-value 
0.02) for the LYM and only on day 21 (p-value 
0.02) for EOS/BAS/MON. 
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Table 2: The effects of ionizing radiation on Erythroid cells (HB, PCV and Total RBC) for the tests and controls. 
 
 
Irradiation                 Day                  ERYTHROID CELLS 
HB (g/dl) PCV(%) TOTAL RBC(x 109/L) 
T C p-value T C p-value T C p-value 
Pre          0 14.1±0.3 14.5±0.46 0.183 45.0±2.0 46.33±2.08 0.06 6.36±0.29 6.36±0.64 1.04 
Post          9 10.53±0.85 14.7±0.25 0.02 30±2.6 47.33±1.15 0.02 4.42±0.24 6.53±0.47 0.03 
p 0.01   0.01   0.01   
14 15.43±0.55 14.7±0.46 0.3 47.6±1.53 46.0±2.0 0.42 6.88±0.39 7.09±0.12 0.47 
p 0.11   0.25   0.23   
21 16.23±0.61 15.37±0.45 0.02 49.3±1.53 53.33±3.06 0.06 7.18±0.22 7.72±0.44 0.06 
p 0.02   0.12   0.08   
 




Table 3: The effects of ionizing radiation on Erythroid cells (MCV, MCH and MCHC) for the tests and control 
   
Irradiation                Day ERYTHROID CELLS 
MCV (fl) MCH (pg) MCHC (g/dl) 
  T C p-value T C p-value T C p-value 
Pre 0 71.33±1.52 70.3±0.6 0.47 21±1.0 21.7±2.08 0.74 30±1 32±1.7 0.32 
Post  9 50±4.5 70.1±1.15 0.01 15.6±0.58 20.7±1.53 0.03 19.6±1.5 31±1.7 0.03 
p 0.02   0.00   0.00   
14 61±1.0 74±2 0.01 21.3±3.2 24±1.7 0.41 32±1.7 31.3±1.5 0.18 
p 0.9   0.9   0.07   
21 75.33±1.53 71.7±1.5 0.05 22.7±2.52 20.7±2.08 0.22 30.3±2.9 29.7±0.6 0.75 
p 0.12   0.49   0.9   
 
* T- Test, † C- Control, ‡ HB- Haemoglobin concentration, § PCV- PACKED Cell Volume, || RBC- Red Blood Cell count
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Table 4: Effects of Ionizing Radiation on Myeloid cells for the Tests and Control 
 
Irradiation Day Myeloid Series 
Total WBC (x 109/L) NEUT (%) LYMP (%) EOS/BAS/MON (%) 
T C p T C p T C P T C p 
Pre   6.9±0.3 6.1±o.3 0.12 10.3±0.6 10±0.0 0.42 89.3±1.2 90±0.0 0.42 0.3±0.6 0.0±0.0 0.84 
Post  9 1.5±0.5 7.3±1.1 0.01 4.3±2.5 11±1 0.04 95.3±3.06 87.3±2.1 0.08 0.3±0.6 0.7±1.5 0.38 
p 0.00   0.05   0.09   0.57   
14 7.5±0.7 6.9±0.3 0.38 24.7±5.8 10±0.0 0.06 73.3±5.8 91.3±2.3 0.05 1.7±0.6 0.0±0.0 0.84 
p 0.26   0.05   0.03   0.67   
21 6.7±0.8 6.4±0.5 0.65 8.7±2.3 10.3±1.5 0.37 81.3±2.3 88.7±1.2 0.01 9.3±1.2 1.0±1.7 0.01 
P 0.63   0.29   0.02   0.02   
* T- Test, † C- Control, ‡ HB- Haemoglobin concentration, § PCV- PACKED Cell Volume, || RBC- Red Blood Cell count 
 
Platelets: Similarly, there was no significant 
difference between the tests and controls in the 
Total Platelets count and MPV during the pre-
irradiation period, p-value 0.92 and 0.09 
respectively. A significant difference between 
tests and controls was noticed only with platelets 
on day 9, p-value <0.01 (Table 5). Comparing the 
pre- and post-irradiation results, a significant drop 
was noticed in Total Platelets counts on day 9 (p-
value 0.006) which significantly increased above 
pre-irradiation value on day 21 (p-value 0.01) 
(Table 5). There were 78.26%, 75% and 30.5% 
reductions in WBC, PLT and RBC counts from 
pre-irradiation to post-irradiation values with p-
values <0.01, 0.01 and 0.01 respectively (Table 
6). 
 







 Total Platelets (X 109/L) MPV 
T C p T C p 
Pre  0 874.7±110.3 865±49.9 0.92 9.3±0.3 10.2±0.2 0.09 
Post 9 218.7±35.8 893±105.7 0.00 9.8±1.1 9.1±2.4 0.48 
p 0.01   0.59   
14 812.7±41.6 853.3±75.6 0.47 7.7±2.3 9.9±0.3 0.21 
p 0.55   0.35   
21 1190±161.9 977.3±146.7 0.20 10.3±0.6 10.1±0.2 0.65 
p 0.01   0.07   
* T- Test, † C- Control, ‡ MPV- Mean Platelet Volume 
 
Table 6: Percentage Reductions RBC, WBC and 
PLT from Pre to Post Irradiation Values. 
 
Irradiation RBC WBC PLT 
Pre 6.36 6.9 874.7 
Post  4.42 1.5 218.7 
p 0.01 0.00 0.01 
% reduction 30.5% 78.26% 75% 
* RBC- Red Blood Cell count, † WBC- White Blood Cell 
count, ‡ PLT- Platelet count 
 
DISCUSSION   
Cells of haemopoietic system are highly sensitive to 
radiation (21). The haemopoietically active bone 
marrow, like other actively dividing tissues in the 
body, is an appropriate model to study radiation 
induced injuries. Injuries to the bone marrow can be 
studied directly by analyzing the bone marrow itself or 
indirectly by analyzing its effects on peripheral blood 
cells. 
 Several methods, though with different 
sensitivity, specificity and accuracy are available to 
evaluate bone marrow activity. Conventional 
radiography, scintigraphy, Computed Tomography, 
Magnetic Resonance Imaging and needle biopsy have 
all been used in the study of bone marrow disorders 
(22).  
 The status of the bone marrow at every stage of 
treatment is of utmost importance in the follow-up of 
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cancer patients on radiotherapy. In fact, the amount of 
viable red bone marrow after each exposure will 
determine whether patients can be further treated with 
radiotherapy or alternatively chemotherapy. 
 In this study, we evaluated the impact of Co60 
ionizing irradiation on bone marrow and peripheral 
blood cells through needle bone marrow biopsy and 
automated peripheral blood cells analyzer using 
Sysmex Automated Analyser Xp-300 respectively on 
days 9, 14 and 21after exposure. Bone marrow 
suppression post-rradiation was unequivocal as 
evidenced by decline in cellularity (as evidenced by 
declining cells counts), replacement of the cellular 
component of marrow with fat as well as reduction in 
all the cell lines in the peripheral circulation. This is 
similar to the findings in most studies (both in animals 
and humans) (21-24). The maximum reduction effects 
of Co60 ionizing radiation on the bone marrow and 
peripheral blood cells were noticed on day 9 post-
irradiation, similar to the findings of Deguan Li et al. 
(25), except lymphocytes and eosinophil/basophil. 
These values subsequently increased to the pre-
irradiation values with complete recovery from days 9 
to 21 post-irradiation. Lymphocyte and MPV initially 
rose above pre-irradiation level untill day 9 and 
subsequently reduced and reached values close to pre-
irradiation values. 
 WBC counts are mostly affected with 78% 
reduction from pre-irradiation values of 6.9 x 109/l to 
1.5 x 109/l with a p-value <0.01. This was was 
followed by PLT and then RBC with percentage 
reduction of 75% and 30.5% and p-values 0.01 and 
0.01 respectively. Theoretically rapidly proliferating 
and differentiating cells of the bone marrow are more 
affected by irradiation than the more mature cells. The 
results of our study revealed that myelopoiesis is most 
affected by irradiation, followed by lymphopoiesis and 
then erythropoiesis. Literature on the degree of 
affectation of each of the marrow cell line by 
radiotherapy is sparse for us to make comparison with 
our findings. Few studies in which findings were close 
to ours was the one in which Granulocyte Colony-
Stimulating Factor (G-CSF) was found to moderately 
reduce the severity and duration of IR- and/or 
chemotherapy-induced BM injury in experimental 
animals and cancer patients (26, 27), and the one in 
which leukocytes and lymphocytes are said to be the 
most highly radiosensitive (28-30). Currently, G-CSF 
is the only treatment recommended to be given to 
radiation victims soon after accidental exposure (31-
33). The ASCO Update Committee agreed 
unanimously that reduction in febrile neutropenia was 
an important clinical outcome that justifies the use of 
CSFs, regardless of impacts on other factors (34). 
 In conclusion, this study demonstrated that total 
body ionizing radiation with Co60 significantly affects 
the bone marrow with maximum reductions in 
peripheral blood cells counts on day 9 post irradiation. 
Myelopoiesis is mostly affected by the radiation, 
followed by megakaryopoiesis and then erythropoiesis. 
Injuries to bone marrow are one of the most important 
side effects of conventional radiotherapy.  This limits 
the success of cancer treatment and adversely affects 
the quality of life of cancer patients. Although this 
study was conducted on Guinea pigs, the findings were 
similar to what was found in human experiments. 
Oncologists and radiation therapists should be aware 
of these findings when spacing radiotherapy courses 
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